The global Healthcare Cmo Market is estimated to be valued at US$ 440.5 Mn or Billion in 2023 and is expected to exhibit a CAGR of 16.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Contract manufacturing organizations (CMOs) offer development and manufacturing services to biotechnology and pharmaceutical companies. They provide cost effective alternatives for outsourcing manufacturing, allowing small to mid-sized pharmaceutical firms to focus on drug development while benefiting from the expertise of specialized manufacturers. The market growth can be attributed to growing outsourcing of drug manufacturing by pharmaceutical companies and rising demand for generics and biosimilars.
Market key trends:
One of the key trends in the healthcare CMO market is the increasing adoption of single-use/disposable technologies. Single-use technologies help minimize the risk of cross-contamination and enable quicker production turnaround times. They reduce cleaning and maintenance costs significantly. Another trend is the rising demand for cell and gene therapies. As novel cell and gene therapies enter late-stage clinical trials, their manufacturing is increasingly being outsourced to capable CMOs with expertise in advanced therapies. Increased regulatory pressures have also led pharma companies to turn to specialist CMOs for ensure compliance with cGMP requirements. Outsourcing to CMOs with advanced compliance expertise helps them focus on drug development.
SWOT Analysis
Strength: The Global Healthcare CMO Market Size benefits from increasing drug development activities and outsourcing of research activities by pharmaceutical companies. This allows CMOs to gain expertise across diverse therapy areas.
Weakness: Stringent regulations and compliance requirements associated with drug development increase operational costs for CMOs. Maintaining quality standards also requires significant investment in infrastructure and training.
Opportunity: Rising demand for biosimilars and cell and gene therapies present major growth opportunities. CMOs can assist biotech companies in commercializing such complex therapies.
Threats: Consolidation among large CMOs increases competition. New entrants from lower-cost regions also intensify market competition globally. Intellectual property issues and data security breaches also pose risks.
Key Takeaways
The global healthcare CMO market is expected to witness high growth, exhibiting a CAGR of 16.% over the forecast period, due to increasing R&D outsourcing among pharmaceutical and biotech companies.
Regional analysis
North America dominates the global healthcare CMO market led by the US due to presence of majority stakeholders. However, Asia Pacific is projected to be the fastest growing region due to low-cost operations and increasing presence of global pharmaceutical companies through outsourcing agreements. Countries such as China, India, and South Korea offer cost advantages to pharmaceutical companies for conducting drug development activities.
Key players
Key players operating in the Healthcare Cmo Market are Accellent, Inc., Boehringer Ingelheim GmbH, Catalent Pharma Solutions, Inc., DSM, Fareva, Greatbatch, Inc., Lonza Group, Patheon, Inc. (Thermo Fisher Scientific Inc.), Piramal Healthcare, Binex, Cytovance Biologics, Emergent BioSolutions Inc., MilliporeSigma, Symbiosis Pharmaceutical Services, Albany Molecular Research Inc., Samsung Biologics, and Symmetry Medical, Inc. Pharmaceutical companies partner with such CMOs to benefit from their economies of scale, advanced infrastructure and technical expertise across various development stages.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. With an MBA in E-commerce, she has an expertise in SEO-optimized content that resonates with industry professionals.